These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22894543)

  • 1. Genetic variability in IGF-1 and IGFBP-3 and body size in early life.
    Poole EM; Tworoger SS; Hankinson SE; Baer HJ
    BMC Public Health; 2012 Aug; 12():659. PubMed ID: 22894543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of body fatness from age 5 to 60 y and plasma biomarker concentrations of the insulin-insulin-like growth factor system.
    Kværner AS; Hang D; Giovannucci EL; Willett WC; Chan AT; Song M
    Am J Clin Nutr; 2018 Aug; 108(2):388-397. PubMed ID: 30101328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
    McGrath M; Lee IM; Buring J; De Vivo I
    Gynecol Oncol; 2011 Feb; 120(2):174-8. PubMed ID: 21078522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
    Su X; Colditz GA; Willett WC; Collins LC; Schnitt SJ; Connolly JL; Pollak MN; Rosner B; Tamimi RM
    Int J Cancer; 2010 Jan; 126(1):180-90. PubMed ID: 19551864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.
    Rice MS; Tworoger SS; Rosner BA; Pollak MN; Hankinson SE; Tamimi RM
    Breast Cancer Res Treat; 2012 Dec; 136(3):805-12. PubMed ID: 23085768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.
    Chang HP; Yang SF; Wang SL; Su PH
    BMC Endocr Disord; 2018 Sep; 18(1):66. PubMed ID: 30249230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein QTL analysis of IGF-I and its binding proteins provides insights into growth biology.
    Bartell E; Fujimoto M; Khoury JC; Khoury PR; Vedantam S; Astley CM; Hirschhorn JN; Dauber A
    Hum Mol Genet; 2020 Aug; 29(15):2625-2636. PubMed ID: 32484228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body shape throughout life and correlations with IGFs and GH.
    Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
    D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Di-nucleotide repeat polymorphisms of the insulin-like growth factor-1 gene and their association with IGF-1, insulin-like growth factor-binding protein-1 and birth size in a Sri-Lankan cohort.
    Jayanthiny P; Tennekoon KH; Karunanayake EH; Kumarasiri JM; Wijesundera AP
    Neonatology; 2011; 100(1):37-43. PubMed ID: 21196777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women.
    Qian B; Zheng H; Yu H; Chen K
    Breast Cancer Res Treat; 2011 Nov; 130(1):217-26. PubMed ID: 21562710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk.
    Tsai CW; Chang WS; Xu Y; Huang M; Bau DT; Gu J
    Mol Carcinog; 2021 Nov; 60(11):726-733. PubMed ID: 34293213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
    Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3.
    Poole EM; Tworoger SS; Hankinson SE; Schernhammer ES; Pollak MN; Baer HJ
    Am J Epidemiol; 2011 Sep; 174(6):642-51. PubMed ID: 21828371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.